Loxo Oncology, Inc

Nuclear Diagnostic Products, part of PharmaLogic, specializes in advancing radiopharmaceutical technology, focusing on the development, manufacture, and distribution of innovative solutions for molecular imaging and theranostics. The company's infrastructure supports both diagnostic and therapeutic applications, leveraging extensive regulatory and quality assurance expertise for successful commercialization. PharmaLogic is dedicated to enhancing patient care through its comprehensive network of radiopharmacies and state-of-the-art manufacturing capabilities. By partnering with healthcare providers, the organization ensures streamlined operational processes and improved diagnostic confidence across the medical community. Generated from the website

Gemini Pharmaeceuticals has been a manufacturer of (over the counter)OTC dietary supplements, herbs and nutritional products for almost 30 years. It is one of the leading providers of research, development, manufacturing logistic and design services to the pharmacueticals and nutritional industries. The company is fully licensed and registered with the Food and Drug Administration (FDA), the Drug Enforcement Agency (DEA) and the New York State Board of Pharmacy. Its line of product includes OTCs, nutraceuticals, vitamins, specialty items, pet supplements and other featured products.

Chartwell Governmental & Specialty Rx LLC, based in Congers, NY, is dedicated to providing innovative pharmaceutical solutions with a focus on specialized products for government and health care sectors. The company is committed to quality and customer service, ensuring a responsive approach to any inquiries related to their offerings. In addition to their headquarters in Congers, Chartwell operates locations in Amityville and Carmel, NY, further enhancing their outreach and capacity to serve their customers effectively. Their range of products includes LymePak, an innovative solution for Lyme disease management, showcasing their dedication to addressing pressing health concerns. Generated from the website